KCNB1增强子功能获得性变异导致家族性ST段压低综合征
本研究对67例家族性ST段压低综合征患者(20个家系)进行连锁分析与全基因组测序,发现 chromosome 20 上KCNB1下游18 kb的非编码变异与心电图表型完全共分离且完全外显。功能实验表明该变异创建MEF2结合位点、增强转录活性,并通过与KCNB1启动子互作调控KCNB1表达,首次将KCNB1与人类心脏电生理及心律失常发生联系起来。
要点
- 家族性ST段压低综合征呈常染色体显性遗传,外显完全。
- KCNB1下游18 kb非编码变异与心电图表型完全共分离。
- 该变异为增强子功能获得性变异,通过MEF2结合增强KCNB1转录。
核心结论
- KCNB1附近的增强子功能获得性变异导致家族性ST段压低综合征,首次将KCNB1与人类心脏电生理和心律失常发生相关联。
研究设计与样本
- 研究共纳入67例家族性ST段压低综合征患者,来自20个家系,进行连锁分析和全基因组测序。
- 对识别的非编码变异在AC16人心肌细胞、肌肉组织和人心肌中进行功能鉴定,并采用计算机分析、荧光素酶及dCas9激活/抑制实验、蛋白-DNA实验、染色体构象捕获(4C)和RNA测序。
主要发现
- 心电图表型在所有家系中呈常染色体显性遗传,连锁分析显示 chromosome 20 上单一峰,全基因组测序在所有受累个体中识别出KCNB1下游18 kb的单一罕见非编码变异。
- 该变异与心电图表型完全共分离,并在所有家系中完全外显。
- 变异创建MEF2结合位点,变异等位基因存在或MEF2共表达增强转录活性。
- dCas9激活/抑制实验显示KCNB1是唯一被该位点持续调控的基因,4C实验在AC16细胞和人肌肉组织中证实位点与KCNB1启动子互作。
- 人心内膜组织表达分析未记录到基因表达改变,可能由表达异质性解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Familial ST-depression syndrome (FSTD) is a recently identified inherited cardiac disease associated with arrhythmias and systolic dysfunction. The underlying genetic aetiology has remained elusive. This study aimed at finding the causative variant. METHODS: A total of 67 FSTD patients (20 families) were studied. Linkage analysis and whole-genome sequencing (WGS) were initially performed. An identified non-coding variant was functionally characterized in AC16 human cardiomyocytes, muscle tissue, and human myocardium. In silico analyses, luciferase and dCas9-activator/repressor assays, protein-DNA experiments, chromosome conformation capture (4C), and RNA sequencing were also performed. RESULTS: The electrocardiographic (ECG) phenotype was inherited in an autosomal dominant manner in all families. Linkage analysis revealed a single peak on chromosome 20, and WGS identified a single, rare, non-coding variant located 18 kb downstream of KCNB1 on chromosome 20 in all affected individuals. Perfect co-segregation with the ECG phenotype was observed together with full penetrance in all families. The variant creates a MEF2-binding site and presence of the variant allele or MEF2 co-expression enhanced transcriptional activity. dCas9-activator/repressor assays showed that KCNB1 was the only gene consistently regulated by the locus and 4C experiments in AC16 cells and human muscle tissue confirmed the locus-KCNB1 promoter interaction. Expression analysis in human endocardial tissue did not document any change in gene expression likely explained by expressional heterogeneity. CONCLUSIONS: A gain-of-function enhancer variant creates a hyperactive regulatory locus that interacts with the KCNB1 promoter and causes FSTD. This is the first time that KCNB1 has been implicated in human cardiac electrophysiology and arrhythmogenesis.
引用
- Christensen AH, Pan G, Marvig RL, et al. Gain-of-function enhancer variant near KCNB1 causes familial ST-depression syndrome. Eur Heart J. 2025. PMID: 40208226. doi:10.1093/eurheartj/ehaf213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。